Home/Filings/4/0001637761-23-000013
4//SEC Filing

Lipschultz Tyler 4

Accession 0001637761-23-000013

CIK 0001637761other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:24 PM ET

Size

8.4 KB

Accession

0001637761-23-000013

Insider Transaction Report

Form 4
Period: 2023-01-01
Lipschultz Tyler
SVP, Orthobiologics and BD
Transactions
  • Tax Payment

    Common Stock

    2023-01-01$8.35/sh3,411$28,482131,284 total
  • Exercise/Conversion

    Common Stock

    2023-01-01+8,362134,695 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-01-018,3620 total
    Common Stock (8,362 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2023. No shares were sold in connection with this transaction.
  • [F3]The reporting person was granted 25,086 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022 and 2023.

Issuer

SeaSpine Holdings Corp

CIK 0001637761

Entity typeother

Related Parties

1
  • filerCIK 0001509284

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:24 PM ET
Size
8.4 KB